Anti-annexin V antibodies: Association with vascular involvement and disease outcome in patients with Systemic sclerosis

Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders

Volumn 3, Issue , 2010, Pages 15-23

  Habeeb, Reem A ^a   Mansour, Howaida E ^a   Abdeldayem, Aya M ^b   Abo Shady, Rania A ^a   Hassan, Iman A ^a   Saafan, Nazek K ^c   Aly, Dalia G ^d  

^a AIN SHAMS UNIVERSITY   (Egypt)

^b AIN SHAMS UNIVERSITY   (Egypt)

^c Ain Shams University Hospital   (Egypt)

^d NATIONAL RESEARCH CENTRE   (Egypt)

Author keywords

Anti annexin V antibodies; Systemic sclerosis; Vascular damage

Indexed keywords

ANTINUCLEAR ANTIBODY; CARDIOLIPIN ANTIBODY; CENTROMERE ANTIBODY; LIPOCORTIN 5 ANTIBODY; PROTEIN ANTIBODY; SCL 70 ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; AUTOIMMUNITY; CLINICAL ARTICLE; COLOR ULTRASOUND FLOWMETRY; CONTROLLED STUDY; DISEASE ACTIVITY; DOPPLER ECHOCARDIOGRAPHY; FEMALE; HIGH RISK PATIENT; HUMAN; PREDICTION; PULMONARY HYPERTENSION; RENAL ARTERY; SYSTEMIC SCLEROSIS; VASCULAR DISEASE; VOLUNTEER;

EID: 77952517163     PISSN: None     EISSN: 11795441     Source Type: Journal    
DOI: 10.4137/cmamd.s4503     Document Type: Article

References (26)

1. Hinchcliff M, Varga J. Systemic sclerosis/scleroderma: a treatable multisystem disease. Am Fam Physician. 2008 Oct 15;78(8):961-8.
2. Le Pavec J, Launay D, Mathai SC, Hassoun PM, Humbert M. Scleroderma lung disease. Clin Rev Allergy Immunol. 2010 Jan 12. [Epub ahead of print]
3. Rosato E, Borghese F, Pisarri S, Salsano F. Laser Doppler perfusion imaging is useful in the study of Raynaud's phenomenon and improves the capillaroscopic diagnosis. J Rheumatol. 2009 Oct;36(10):2257-63.
4. Zabek J, Palacz A, Pyka J. Antinucleolar antibodies in diagnosis of antiphospholipid syndrome. Pol Arch Med Wewn. 2008;118 Suppl:25-30.
5. Esposito G, Tamby MC, Chanseaud Y. Anti-annexin V antibodies: are they prothrombotic? Autoimmun Rev. 2005 Jan;4(1):55-60.
6. Ishikawa H. Revised diagnostic criteria for progressive systemic sclerosis. Ryumachi. 1984 Jun;24(3):198-203.
7. Hudson M, Julien M, Baron M (Canadian Scleroderma Research Group), Steele R. Development of the scleroderma disease activity index (SDAI). Arthritis Rheum. 2009;60 Suppl 10:442.
8. Amjadi S, Maranian P, Furst DE, et al. Course of the modified Rodnan skin thickness score in systemic sclerosis clinical trials: analysis of three large multicenter, double-blind, randomized controlled trials. Arthritis Rheum. 2009 Aug;60(8):2490-8.
9. Cutolo M, Sulli A, Pizzorni C, Accardo S. Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis. J Rheumatol. 2000 Jan;27(1):155-60.
10. Müller-Ladner U, Distler O, Ibba-Manneschi L, Neumann E, Gay S. Mechanisms of vascular damage in systemic sclerosis. Autoimmunity. 2009 Nov; 42(7):587-95.
11. Al-Adhadh RN, Al-Sayed TA. Clinical features of systemic sclerosis. Saudi Med J. 2001 Apr;22(4):333-6.
12. Ostojić P, Damjanov N. Different clinical features in patients with limited and diffuse cutaneous systemic sclerosis. Clin Rheumatol. 2006 Jul; 25(4):453-7.
13. Admou B, Essaadouni L, Amal S, Arji N, Chabaa L, El Aouad R. Autoantibodies in systemic sclerosis: clinical interest and diagnosis approach. Ann Biol Clin (Paris). 2009 May-Jun;67(3):273-81.
14. Sugiura K, Muro Y. Anti-annexin V antibodies and digital ischemia in patients with scleroderma. J Rheumatol. 1999 Oct;26(10):2168-72.
15. Lakos G, Kiss E, Regeczy N, et al. Antiprothrombin and anti-annexin V antibodies imply risk of thrombosis in patients with systemic autoimmune diseases. J Rheumatol. 2000 Apr;27(4):924-9.
16. Hanly JG, Smith SA, Anderson D. Inhibition of annexin V binding to cardiolipin and thrombin generation in an unselected population with venous thrombosis. J Rheumatol. 2003 Sep;30(9):1990-3.
17. Kenik JG, Maricq HR, Bole GG. Blind evaluation of the diagnostic specificity of nailfold capillary microscopy in the connective tissue diseases. Arthritis Rheum. 1981 Jul;24(7):885-91.
18. Sato LT, Kayser C, Andrade LE. Nailfold capillaroscopy abnormalities correlate with cutaneous and visceral involvement in systemic sclerosis patients. Acta Reumatol Port. 2009 Apr-Jun;34(2A):219-27.
19. Chang B, Wigley FM, White B, Wise RA. Scleroderma patients with combined pulmonary hypertension and interstitial lung disease. J Rheumatol. 2003 Nov;30(11):2398-405.
20. Steen V. Advancements in diagnosis of pulmonary arterial hypertension in scleroderma. Arthritis Rheum. 2005 Dec;52(12):3698-700.
21. Mukerjee D, St George D, Knight C, et al. Echocardiography and pulmonary function as screening tests for pulmonary arterial hypertension in systemic sclerosis. Rheumatology (Oxford). 2004 Apr;43(4):461-6. Epub 2004 Jan 6.
22. Hachulla E, Gressin V, Guillevin L, et al. Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter study. Arthritis Rheum. 2005 Dec;52(12):3792-800.
23. Rivolta R, Mascagni B, Berruti V, et al. Renal vascular damage in systemic sclerosis patients without clinical evidence of nephropathy. Arthritis Rheum. 1996 Jun;39(6):1030-4.
24. Nishijima C, Sato S, Hasegawa M, et al. Renal vascular damage in Japanese patients with systemic sclerosis. Rheumatology (Oxford). 2001 Apr;40(4): 406-9.
25. Aikimbaev KS, Canataroǧlu A, Ozbek S, Usal A. Renal vascular resistance in progressive systemic sclerosis: evaluation with duplex Doppler ultrasound. Angiology. 2001 Oct;52(10):697-701.
26. Amabile N, Guérin AP, Leroyer A, et al. Circulating endothelial microparticles are associated with vascular dysfunction in patients with end-stage renal failure. J Am Soc Nephrol. 2005 Nov;16(11):3381-8.